Paul K Laikind Insider Trading $MBRX METABASIS THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul K Laikind.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul K Laikind. Paul K Laikind is Chief Executive Officer in METABASIS THERAPEUTICS INC ($MBRX) and Director in METABASIS THERAPEUTICS INC ($MBRX).
Paul K Laikind in METABASIS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul K Laikind: Director, Chief Executive Officer
Holdings: 707,220 shares
Current Value: $1,272,996
Latest Transaction: Jun 25 2009
$MBRX Market Capitalization: $18.08M
$MBRX Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul K Laikind in METABASIS THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2009 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Director | Option Exercise | A | 0.41 | 5,000 | 2,050 | 5,000 | |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.53 | 100 | 53 | 707,220 | 707.1 K to 707.2 K (+0.01 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.49 | 100 | 49 | 707,120 | 707 K to 707.1 K (+0.01 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.57 | 837 | 477 | 707,020 | 706.2 K to 707 K (+0.12 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.55 | 100 | 55 | 706,183 | 706.1 K to 706.2 K (+0.01 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.75 | 963 | 722 | 706,083 | 705.1 K to 706.1 K (+0.14 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.74 | 200 | 148 | 705,120 | 704.9 K to 705.1 K (+0.03 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.70 | 800 | 560 | 704,920 | 704.1 K to 704.9 K (+0.11 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.69 | 500 | 345 | 704,120 | 703.6 K to 704.1 K (+0.07 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.68 | 500 | 340 | 703,620 | 703.1 K to 703.6 K (+0.07 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.67 | 100 | 67 | 703,120 | 703 K to 703.1 K (+0.01 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.63 | 400 | 252 | 703,020 | 702.6 K to 703 K (+0.06 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.56 | 100 | 56 | 702,620 | 702.5 K to 702.6 K (+0.01 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.59 | 300 | 177 | 702,520 | 702.2 K to 702.5 K (+0.04 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.56 | 500 | 280 | 702,220 | 701.7 K to 702.2 K (+0.07 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.51 | 100 | 51 | 701,720 | 701.6 K to 701.7 K (+0.01 %) |
| Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.49 | 400 | 196 | 701,620 | 701.2 K to 701.6 K (+0.06 %) |
| Apr 03 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Option Exercise | A | 2.10 | 180,000 | 378,000 | 180,000 | |
| Mar 19 2007 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Option Exercise | A | 7.60 | 100,000 | 760,000 | 100,000 | |
| Mar 21 2006 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Option Exercise | A | 9.03 | 125,000 | 1,128,750 | 125,000 |
Page: 1